Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

Macrophage internalization of modified lipoproteins is thought to play a critical role in the initiation of atherogenesis. Two scavenger receptors, scavenger receptor A (SR-A) and CD36, have been centrally implicated in this lipid uptake process. Previous studies showed that these receptors mediated...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation 2005-08, Vol.115 (8), p.2192-2201
Hauptverfasser: Moore, Kathryn J, Kunjathoor, Vidya V, Koehn, Stephanie L, Manning, Jennifer J, Tseng, Anita A, Silver, Jessica M, McKee, Mary, Freeman, Mason W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2201
container_issue 8
container_start_page 2192
container_title The Journal of clinical investigation
container_volume 115
creator Moore, Kathryn J
Kunjathoor, Vidya V
Koehn, Stephanie L
Manning, Jennifer J
Tseng, Anita A
Silver, Jessica M
McKee, Mary
Freeman, Mason W
description Macrophage internalization of modified lipoproteins is thought to play a critical role in the initiation of atherogenesis. Two scavenger receptors, scavenger receptor A (SR-A) and CD36, have been centrally implicated in this lipid uptake process. Previous studies showed that these receptors mediated the majority of cholesterol ester accumulation in macrophages exposed to oxidized LDL and that mice with deletions of either receptor exhibited marked reductions in atherosclerosis. This work has contributed to an atherosclerosis paradigm: scavenger receptor-mediated oxidized lipoprotein uptake is required for foam cell formation and atherogenesis. In this study, Apoe-/- mice lacking SR-A or CD36, backcrossed into the C57BL/6 strain for 7 generations, were fed an atherogenic diet for 8 weeks. Hyperlipidemic Cd36-/-Apoe-/- and Msr1-/-Apoe-/- mice showed significant reductions in peritoneal macrophage lipid accumulation in vivo; however, in contrast with previous reports, this was associated with increased aortic sinus lesion areas. Characterization of aortic sinus lesions by electron microscopy and immunohistochemistry showed abundant macrophage foam cells, indicating that lipid uptake by intimal macrophages occurs in the absence of CD36 or SR-A. These data show that alternative lipid uptake mechanisms may contribute to macrophage cholesterol ester accumulation in vivo and suggest that the roles of SR-A and CD36 as proatherosclerotic mediators of modified LDL uptake in vivo need to be reassessed.
doi_str_mv 10.1172/JCI24061
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1180534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>881332661</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-a6b7b7eb21891e4ac2cc0746debe55f4110adcca21868cdc6bd765cc81bca1653</originalsourceid><addsrcrecordid>eNpdkc1u1DAUhS0EokNB4gmQxaLqJuCb2I5ng1QNhbYaiQ2sLefmTscliYOdDJpn6Evj0qFAF75enE_n_hzGXoN4B1CX769Wl6UUGp6wBShlClNW5ilbCFFCsawrc8RepHQjBEip5HN2BFrUSmixYLfrkBIPGx4JaZxCLHpqvZuo5Z0ffcvncXLfie-84wndjoZrig8wP-O5rD5Wmo9u2v50-8TbQIkPYeKup86HmL141iiGhN1d9Yn7gW_3I8XfLaj3yPOjl-zZxnWJXh3-Y_bt0_nX1UWx_vL5cnW2LlBWeiqcbuqmpqYEswSSDktEUUvdUkNKbSSAcC2iy7o22KJu2lorRAMNOtCqOmYf7n3HucnbIg1TdJ0do-9d3NvgvP1fGfzWXoedBTBCVTIbnBwMYvgxU5ps7xNS17mBwpysNlIKqSCDbx-BN2GOQ17OlkKoUi3VMkOn9xDm46RIm4dJQNi7eO2feDP65t_J_4KHPKtf5TWjaw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200525959</pqid></control><display><type>article</type><title>Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Moore, Kathryn J ; Kunjathoor, Vidya V ; Koehn, Stephanie L ; Manning, Jennifer J ; Tseng, Anita A ; Silver, Jessica M ; McKee, Mary ; Freeman, Mason W</creator><creatorcontrib>Moore, Kathryn J ; Kunjathoor, Vidya V ; Koehn, Stephanie L ; Manning, Jennifer J ; Tseng, Anita A ; Silver, Jessica M ; McKee, Mary ; Freeman, Mason W</creatorcontrib><description>Macrophage internalization of modified lipoproteins is thought to play a critical role in the initiation of atherogenesis. Two scavenger receptors, scavenger receptor A (SR-A) and CD36, have been centrally implicated in this lipid uptake process. Previous studies showed that these receptors mediated the majority of cholesterol ester accumulation in macrophages exposed to oxidized LDL and that mice with deletions of either receptor exhibited marked reductions in atherosclerosis. This work has contributed to an atherosclerosis paradigm: scavenger receptor-mediated oxidized lipoprotein uptake is required for foam cell formation and atherogenesis. In this study, Apoe-/- mice lacking SR-A or CD36, backcrossed into the C57BL/6 strain for 7 generations, were fed an atherogenic diet for 8 weeks. Hyperlipidemic Cd36-/-Apoe-/- and Msr1-/-Apoe-/- mice showed significant reductions in peritoneal macrophage lipid accumulation in vivo; however, in contrast with previous reports, this was associated with increased aortic sinus lesion areas. Characterization of aortic sinus lesions by electron microscopy and immunohistochemistry showed abundant macrophage foam cells, indicating that lipid uptake by intimal macrophages occurs in the absence of CD36 or SR-A. These data show that alternative lipid uptake mechanisms may contribute to macrophage cholesterol ester accumulation in vivo and suggest that the roles of SR-A and CD36 as proatherosclerotic mediators of modified LDL uptake in vivo need to be reassessed.</description><identifier>ISSN: 0021-9738</identifier><identifier>EISSN: 1558-8238</identifier><identifier>DOI: 10.1172/JCI24061</identifier><identifier>PMID: 16075060</identifier><language>eng</language><publisher>United States: American Society for Clinical Investigation</publisher><subject>Animals ; Apolipoproteins E - genetics ; Apolipoproteins E - metabolism ; Arteriosclerosis - genetics ; Arteriosclerosis - metabolism ; Arteriosclerosis - pathology ; Atherosclerosis ; Biomedical research ; CD36 Antigens - genetics ; CD36 Antigens - metabolism ; Cholesterol ; Cholesterol Esters - metabolism ; Chromatography ; Diet, Atherogenic ; Foam Cells - metabolism ; Foam Cells - pathology ; Hyperlipidemias - genetics ; Hyperlipidemias - metabolism ; Hyperlipidemias - pathology ; Hypotheses ; Lipids ; Lipoproteins ; Lipoproteins, LDL - metabolism ; Macrophages, Peritoneal - metabolism ; Macrophages, Peritoneal - pathology ; Mice ; Mice, Knockout ; Oxidation ; Receptors, Immunologic - genetics ; Receptors, Immunologic - metabolism ; Receptors, Scavenger ; Scavenger Receptors, Class A ; Sinus of Valsalva - metabolism ; Sinus of Valsalva - pathology ; Sinuses</subject><ispartof>The Journal of clinical investigation, 2005-08, Vol.115 (8), p.2192-2201</ispartof><rights>Copyright American Society for Clinical Investigation Aug 2005</rights><rights>Copyright © 2005, American Society for Clinical Investigation 2005</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-a6b7b7eb21891e4ac2cc0746debe55f4110adcca21868cdc6bd765cc81bca1653</citedby><cites>FETCH-LOGICAL-c436t-a6b7b7eb21891e4ac2cc0746debe55f4110adcca21868cdc6bd765cc81bca1653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180534/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1180534/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16075060$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Moore, Kathryn J</creatorcontrib><creatorcontrib>Kunjathoor, Vidya V</creatorcontrib><creatorcontrib>Koehn, Stephanie L</creatorcontrib><creatorcontrib>Manning, Jennifer J</creatorcontrib><creatorcontrib>Tseng, Anita A</creatorcontrib><creatorcontrib>Silver, Jessica M</creatorcontrib><creatorcontrib>McKee, Mary</creatorcontrib><creatorcontrib>Freeman, Mason W</creatorcontrib><title>Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice</title><title>The Journal of clinical investigation</title><addtitle>J Clin Invest</addtitle><description>Macrophage internalization of modified lipoproteins is thought to play a critical role in the initiation of atherogenesis. Two scavenger receptors, scavenger receptor A (SR-A) and CD36, have been centrally implicated in this lipid uptake process. Previous studies showed that these receptors mediated the majority of cholesterol ester accumulation in macrophages exposed to oxidized LDL and that mice with deletions of either receptor exhibited marked reductions in atherosclerosis. This work has contributed to an atherosclerosis paradigm: scavenger receptor-mediated oxidized lipoprotein uptake is required for foam cell formation and atherogenesis. In this study, Apoe-/- mice lacking SR-A or CD36, backcrossed into the C57BL/6 strain for 7 generations, were fed an atherogenic diet for 8 weeks. Hyperlipidemic Cd36-/-Apoe-/- and Msr1-/-Apoe-/- mice showed significant reductions in peritoneal macrophage lipid accumulation in vivo; however, in contrast with previous reports, this was associated with increased aortic sinus lesion areas. Characterization of aortic sinus lesions by electron microscopy and immunohistochemistry showed abundant macrophage foam cells, indicating that lipid uptake by intimal macrophages occurs in the absence of CD36 or SR-A. These data show that alternative lipid uptake mechanisms may contribute to macrophage cholesterol ester accumulation in vivo and suggest that the roles of SR-A and CD36 as proatherosclerotic mediators of modified LDL uptake in vivo need to be reassessed.</description><subject>Animals</subject><subject>Apolipoproteins E - genetics</subject><subject>Apolipoproteins E - metabolism</subject><subject>Arteriosclerosis - genetics</subject><subject>Arteriosclerosis - metabolism</subject><subject>Arteriosclerosis - pathology</subject><subject>Atherosclerosis</subject><subject>Biomedical research</subject><subject>CD36 Antigens - genetics</subject><subject>CD36 Antigens - metabolism</subject><subject>Cholesterol</subject><subject>Cholesterol Esters - metabolism</subject><subject>Chromatography</subject><subject>Diet, Atherogenic</subject><subject>Foam Cells - metabolism</subject><subject>Foam Cells - pathology</subject><subject>Hyperlipidemias - genetics</subject><subject>Hyperlipidemias - metabolism</subject><subject>Hyperlipidemias - pathology</subject><subject>Hypotheses</subject><subject>Lipids</subject><subject>Lipoproteins</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Macrophages, Peritoneal - metabolism</subject><subject>Macrophages, Peritoneal - pathology</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Oxidation</subject><subject>Receptors, Immunologic - genetics</subject><subject>Receptors, Immunologic - metabolism</subject><subject>Receptors, Scavenger</subject><subject>Scavenger Receptors, Class A</subject><subject>Sinus of Valsalva - metabolism</subject><subject>Sinus of Valsalva - pathology</subject><subject>Sinuses</subject><issn>0021-9738</issn><issn>1558-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkc1u1DAUhS0EokNB4gmQxaLqJuCb2I5ng1QNhbYaiQ2sLefmTscliYOdDJpn6Evj0qFAF75enE_n_hzGXoN4B1CX769Wl6UUGp6wBShlClNW5ilbCFFCsawrc8RepHQjBEip5HN2BFrUSmixYLfrkBIPGx4JaZxCLHpqvZuo5Z0ffcvncXLfie-84wndjoZrig8wP-O5rD5Wmo9u2v50-8TbQIkPYeKup86HmL141iiGhN1d9Yn7gW_3I8XfLaj3yPOjl-zZxnWJXh3-Y_bt0_nX1UWx_vL5cnW2LlBWeiqcbuqmpqYEswSSDktEUUvdUkNKbSSAcC2iy7o22KJu2lorRAMNOtCqOmYf7n3HucnbIg1TdJ0do-9d3NvgvP1fGfzWXoedBTBCVTIbnBwMYvgxU5ps7xNS17mBwpysNlIKqSCDbx-BN2GOQ17OlkKoUi3VMkOn9xDm46RIm4dJQNi7eO2feDP65t_J_4KHPKtf5TWjaw</recordid><startdate>200508</startdate><enddate>200508</enddate><creator>Moore, Kathryn J</creator><creator>Kunjathoor, Vidya V</creator><creator>Koehn, Stephanie L</creator><creator>Manning, Jennifer J</creator><creator>Tseng, Anita A</creator><creator>Silver, Jessica M</creator><creator>McKee, Mary</creator><creator>Freeman, Mason W</creator><general>American Society for Clinical Investigation</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>S0X</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200508</creationdate><title>Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice</title><author>Moore, Kathryn J ; Kunjathoor, Vidya V ; Koehn, Stephanie L ; Manning, Jennifer J ; Tseng, Anita A ; Silver, Jessica M ; McKee, Mary ; Freeman, Mason W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-a6b7b7eb21891e4ac2cc0746debe55f4110adcca21868cdc6bd765cc81bca1653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Apolipoproteins E - genetics</topic><topic>Apolipoproteins E - metabolism</topic><topic>Arteriosclerosis - genetics</topic><topic>Arteriosclerosis - metabolism</topic><topic>Arteriosclerosis - pathology</topic><topic>Atherosclerosis</topic><topic>Biomedical research</topic><topic>CD36 Antigens - genetics</topic><topic>CD36 Antigens - metabolism</topic><topic>Cholesterol</topic><topic>Cholesterol Esters - metabolism</topic><topic>Chromatography</topic><topic>Diet, Atherogenic</topic><topic>Foam Cells - metabolism</topic><topic>Foam Cells - pathology</topic><topic>Hyperlipidemias - genetics</topic><topic>Hyperlipidemias - metabolism</topic><topic>Hyperlipidemias - pathology</topic><topic>Hypotheses</topic><topic>Lipids</topic><topic>Lipoproteins</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Macrophages, Peritoneal - metabolism</topic><topic>Macrophages, Peritoneal - pathology</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Oxidation</topic><topic>Receptors, Immunologic - genetics</topic><topic>Receptors, Immunologic - metabolism</topic><topic>Receptors, Scavenger</topic><topic>Scavenger Receptors, Class A</topic><topic>Sinus of Valsalva - metabolism</topic><topic>Sinus of Valsalva - pathology</topic><topic>Sinuses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moore, Kathryn J</creatorcontrib><creatorcontrib>Kunjathoor, Vidya V</creatorcontrib><creatorcontrib>Koehn, Stephanie L</creatorcontrib><creatorcontrib>Manning, Jennifer J</creatorcontrib><creatorcontrib>Tseng, Anita A</creatorcontrib><creatorcontrib>Silver, Jessica M</creatorcontrib><creatorcontrib>McKee, Mary</creatorcontrib><creatorcontrib>Freeman, Mason W</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of clinical investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moore, Kathryn J</au><au>Kunjathoor, Vidya V</au><au>Koehn, Stephanie L</au><au>Manning, Jennifer J</au><au>Tseng, Anita A</au><au>Silver, Jessica M</au><au>McKee, Mary</au><au>Freeman, Mason W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice</atitle><jtitle>The Journal of clinical investigation</jtitle><addtitle>J Clin Invest</addtitle><date>2005-08</date><risdate>2005</risdate><volume>115</volume><issue>8</issue><spage>2192</spage><epage>2201</epage><pages>2192-2201</pages><issn>0021-9738</issn><eissn>1558-8238</eissn><abstract>Macrophage internalization of modified lipoproteins is thought to play a critical role in the initiation of atherogenesis. Two scavenger receptors, scavenger receptor A (SR-A) and CD36, have been centrally implicated in this lipid uptake process. Previous studies showed that these receptors mediated the majority of cholesterol ester accumulation in macrophages exposed to oxidized LDL and that mice with deletions of either receptor exhibited marked reductions in atherosclerosis. This work has contributed to an atherosclerosis paradigm: scavenger receptor-mediated oxidized lipoprotein uptake is required for foam cell formation and atherogenesis. In this study, Apoe-/- mice lacking SR-A or CD36, backcrossed into the C57BL/6 strain for 7 generations, were fed an atherogenic diet for 8 weeks. Hyperlipidemic Cd36-/-Apoe-/- and Msr1-/-Apoe-/- mice showed significant reductions in peritoneal macrophage lipid accumulation in vivo; however, in contrast with previous reports, this was associated with increased aortic sinus lesion areas. Characterization of aortic sinus lesions by electron microscopy and immunohistochemistry showed abundant macrophage foam cells, indicating that lipid uptake by intimal macrophages occurs in the absence of CD36 or SR-A. These data show that alternative lipid uptake mechanisms may contribute to macrophage cholesterol ester accumulation in vivo and suggest that the roles of SR-A and CD36 as proatherosclerotic mediators of modified LDL uptake in vivo need to be reassessed.</abstract><cop>United States</cop><pub>American Society for Clinical Investigation</pub><pmid>16075060</pmid><doi>10.1172/JCI24061</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9738
ispartof The Journal of clinical investigation, 2005-08, Vol.115 (8), p.2192-2201
issn 0021-9738
1558-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1180534
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Animals
Apolipoproteins E - genetics
Apolipoproteins E - metabolism
Arteriosclerosis - genetics
Arteriosclerosis - metabolism
Arteriosclerosis - pathology
Atherosclerosis
Biomedical research
CD36 Antigens - genetics
CD36 Antigens - metabolism
Cholesterol
Cholesterol Esters - metabolism
Chromatography
Diet, Atherogenic
Foam Cells - metabolism
Foam Cells - pathology
Hyperlipidemias - genetics
Hyperlipidemias - metabolism
Hyperlipidemias - pathology
Hypotheses
Lipids
Lipoproteins
Lipoproteins, LDL - metabolism
Macrophages, Peritoneal - metabolism
Macrophages, Peritoneal - pathology
Mice
Mice, Knockout
Oxidation
Receptors, Immunologic - genetics
Receptors, Immunologic - metabolism
Receptors, Scavenger
Scavenger Receptors, Class A
Sinus of Valsalva - metabolism
Sinus of Valsalva - pathology
Sinuses
title Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A17%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Loss%20of%20receptor-mediated%20lipid%20uptake%20via%20scavenger%20receptor%20A%20or%20CD36%20pathways%20does%20not%20ameliorate%20atherosclerosis%20in%20hyperlipidemic%20mice&rft.jtitle=The%20Journal%20of%20clinical%20investigation&rft.au=Moore,%20Kathryn%20J&rft.date=2005-08&rft.volume=115&rft.issue=8&rft.spage=2192&rft.epage=2201&rft.pages=2192-2201&rft.issn=0021-9738&rft.eissn=1558-8238&rft_id=info:doi/10.1172/JCI24061&rft_dat=%3Cproquest_pubme%3E881332661%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200525959&rft_id=info:pmid/16075060&rfr_iscdi=true